FIELD: chemistry.
SUBSTANCE: present invention pertains to α-2A/α-1A selective agonist, which is a compound with formula 
, as well as to a pharmaceutical composition, which contains a pharmaceutical carrier and a therapeutic effective quantity of α-2A/α-1A selective agonist, which contains a compound with structure 1.
EFFECT: obtaining selective agonist which can be used for preventing or alleviating neurological conditions without an accompanying sedative effect during extraneous administration.
6 cl, 2 tbl, 2 ex, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD AND COMPOSITIONS FOR PAIN RELIEF | 2003 |
|
RU2329062C2 |
| 4-(PHENYLMETHYL AND SUBSTITUTED-PHENYLMETHYL)-IMIDAZOLE-2-THIONIES, ACTING AS SPECIFIC ALPHA-ADRENERGIC AGONISTS | 2005 |
|
RU2383535C2 |
| ANESTHETIC COMPOSITION COMPRISING NMDA-ANTAGONIST AND ALPHA-2-ADRENERGIC AGONIST | 2000 |
|
RU2244558C2 |
| AGONISTS OF ALPHA-2B OR 2B/2C ADRENORECEPTORS FOR NEURODEGENERATIVE DISEASES TREATMENT | 2003 |
|
RU2330649C2 |
| INJECTED COMBINATION OF AGONISTS OF ADRENERGIC RECEPTORS WITH FILLERS FOR REDUCTION OF SKIN RESPONSES TO INJECTION | 2010 |
|
RU2530604C2 |
| APPLICATION OF (2-IMIDAZOLIN-2-YLAMINO) QUINOXALINES IN DEMENTIA AND PARKINSON'S DISEASE TREATMENT | 2003 |
|
RU2332218C2 |
| COMPOSITION CONTAINING ALPHA-2-ADRENERGIC AGONISTS | 2001 |
|
RU2311928C2 |
| METHOD OF ACTIVATION OF REGULATORY T-CELLS OF ALPHA-2B ADRENERGIC RECEPTOR AGONISTS | 2011 |
|
RU2599495C2 |
| (R)-PIRLINDOLE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR USE IN MEDICINE | 2014 |
|
RU2695607C2 |
| METHODS, COMPOSITIONS AND PREPARATIONS FOR TREATING THYROID-ASSOCIATED OPHTHALMOPATHY | 2007 |
|
RU2417100C2 |
